Isoflavones and Acute-phase Response in Chronic Renal Failure
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded dietary intervention in hemodialysis patients to
determine the clinical and metabolic effects of soy isoflavones on disease activity,
including improvement of blood markers of acute-phase response, and decreased blood levels of
markers of metabolic bone disease.
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)